"The patient can then either be cleared to leave, or quickly progressed to specialist cardiac care," said Pickering, who helped trial the test as part of a collaboration between Canterbury District Health Board (CDHB) and the Otago University-hosted Christchurch Heart Institute.
"The benefits are therefore a speedier diagnosis and treatment, and a reduction in the time and effort current testing procedures require of ED staff, beds, and equipment."
Another senior author, CDHB emergency medicine specialist Dr Martin Than, explained current point-of-care tests could lack the precision of the new method, which was centred around a measurement of a protein in the blood called cardiac troponin.
The observational study, conducted between 2016 and 2017, at Christchurch Hospital's emergency department, included about 350 patients with symptoms of a heart attack.
So far, testing had shown that close to half could have the risk of heart attack safely excluded soon after arrival at the ED.
Wider study was in progress, and there were plans to roll out the study across 10 DHBs next year.
"Our results have extremely exciting potential for not only EDs, but also isolated healthcare providers - such as those in rural communities – worldwide," Than said.
"Even the concerning impact heart disease and other cardio-vascular conditions have on not only New Zealand society but also internationally, we have something that could benefit tens of millions of patients globally, while also freeing up EDs and isolated healthcare staff and resources."
The study was supported by the Canterbury Medical Research Foundation, the Emergency Care Foundation, the Health Research Council and the New Zealand Heart Foundation.